NSCLC: primary tumor size--radiation dose-related accelerated, twice daily radiotherapy by target splitting, preceded by 2 cycles of chemotherapy--first results of a prospective study.

Karl Wurstbauer; Heinz Deutschmann; Peter Kopp; Manfred Kranzinger; Florian Merz; Olaf Nairz; Michael Studnicka; Felix Sedlmayer

doi:10.1007/s00066-007-2015-4

NSCLC: primary tumor size--radiation dose-related accelerated, twice daily radiotherapy by target splitting, preceded by 2 cycles of chemotherapy--first results of a prospective study.

Karl Wurstbauer^* (First author), Heinz Deutschmann (Co-author), Peter Kopp, Manfred Kranzinger, Florian Merz, Olaf Nairz, Michael Studnicka (Co-author), Felix Sedlmayer (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Original Article › peer-review

7 Citations (Web of Science)

Original language	English
Pages (from-to)	38-40
Journal	STRAHLENTHERAPIE UND ONKOLOGIE
Volume	183 Spec No 2
DOIs	https://doi.org/10.1007/s00066-007-2015-4
Publication status	Published - 2007

Keywords

CELL LUNG-CANCER
INDUCTION CHEMOTHERAPY
THORACIC RADIOTHERAPY
SEQUENTIAL CHEMORADIOTHERAPY
PHASE-III
CONCURRENT
ESCALATION
CARCINOMA
CISPLATIN
SURVIVAL

Access to Document

10.1007/s00066-007-2015-4

Cite this

Wurstbauer, K., Deutschmann, H., Kopp, P., Kranzinger, M., Merz, F., Nairz, O., Studnicka, M., & Sedlmayer, F. (2007). NSCLC: primary tumor size--radiation dose-related accelerated, twice daily radiotherapy by target splitting, preceded by 2 cycles of chemotherapy--first results of a prospective study. STRAHLENTHERAPIE UND ONKOLOGIE , 183 Spec No 2, 38-40. https://doi.org/10.1007/s00066-007-2015-4

Wurstbauer, Karl ; Deutschmann, Heinz ; Kopp, Peter et al. / NSCLC: primary tumor size--radiation dose-related accelerated, twice daily radiotherapy by target splitting, preceded by 2 cycles of chemotherapy--first results of a prospective study. In: STRAHLENTHERAPIE UND ONKOLOGIE 2007 ; Vol. 183 Spec No 2. pp. 38-40.

@article{4f6ad2da97de4f878ca35fb6bbaa4d8b,

title = "NSCLC: primary tumor size--radiation dose-related accelerated, twice daily radiotherapy by target splitting, preceded by 2 cycles of chemotherapy--first results of a prospective study.",

keywords = "CELL LUNG-CANCER, INDUCTION CHEMOTHERAPY, THORACIC RADIOTHERAPY, SEQUENTIAL CHEMORADIOTHERAPY, PHASE-III, CONCURRENT, ESCALATION, CARCINOMA, CISPLATIN, SURVIVAL",

author = "Karl Wurstbauer and Heinz Deutschmann and Peter Kopp and Manfred Kranzinger and Florian Merz and Olaf Nairz and Michael Studnicka and Felix Sedlmayer",

year = "2007",

doi = "10.1007/s00066-007-2015-4",

language = "English",

volume = "183 Spec No 2",

pages = "38--40",

journal = "STRAHLENTHERAPIE UND ONKOLOGIE ",

issn = "0179-7158",

publisher = "Springer Nature",

}

Wurstbauer, K, Deutschmann, H, Kopp, P, Kranzinger, M, Merz, F, Nairz, O, Studnicka, M & Sedlmayer, F 2007, 'NSCLC: primary tumor size--radiation dose-related accelerated, twice daily radiotherapy by target splitting, preceded by 2 cycles of chemotherapy--first results of a prospective study.', STRAHLENTHERAPIE UND ONKOLOGIE , vol. 183 Spec No 2, pp. 38-40. https://doi.org/10.1007/s00066-007-2015-4

NSCLC: primary tumor size--radiation dose-related accelerated, twice daily radiotherapy by target splitting, preceded by 2 cycles of chemotherapy--first results of a prospective study. / Wurstbauer, Karl (First author); Deutschmann, Heinz (Co-author); Kopp, Peter et al.
In: STRAHLENTHERAPIE UND ONKOLOGIE , Vol. 183 Spec No 2, 2007, p. 38-40.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - NSCLC: primary tumor size--radiation dose-related accelerated, twice daily radiotherapy by target splitting, preceded by 2 cycles of chemotherapy--first results of a prospective study.

AU - Wurstbauer, Karl

AU - Deutschmann, Heinz

AU - Kopp, Peter

AU - Kranzinger, Manfred

AU - Merz, Florian

AU - Nairz, Olaf

AU - Studnicka, Michael

AU - Sedlmayer, Felix

PY - 2007

Y1 - 2007

KW - CELL LUNG-CANCER

KW - INDUCTION CHEMOTHERAPY

KW - THORACIC RADIOTHERAPY

KW - SEQUENTIAL CHEMORADIOTHERAPY

KW - PHASE-III

KW - CONCURRENT

KW - ESCALATION

KW - CARCINOMA

KW - CISPLATIN

KW - SURVIVAL

U2 - 10.1007/s00066-007-2015-4

DO - 10.1007/s00066-007-2015-4

M3 - Original Article

C2 - 18167008

SN - 0179-7158

VL - 183 Spec No 2

SP - 38

EP - 40

JO - STRAHLENTHERAPIE UND ONKOLOGIE

JF - STRAHLENTHERAPIE UND ONKOLOGIE

ER -

Wurstbauer K, Deutschmann H, Kopp P, Kranzinger M, Merz F, Nairz O et al. NSCLC: primary tumor size--radiation dose-related accelerated, twice daily radiotherapy by target splitting, preceded by 2 cycles of chemotherapy--first results of a prospective study. STRAHLENTHERAPIE UND ONKOLOGIE . 2007;183 Spec No 2:38-40. doi: 10.1007/s00066-007-2015-4